| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adapting the cystic fibrosis care model: Perspectives from people with CF, caregivers, and members of CF care teams
|
Tran, Quynh T.
|
|
|
23 |
6 |
p. 1066-1071
|
artikel
|
| 2 |
Calibrating sweat chloride levels to CFTR activity via ETI effects on CF subjects with one or two F508DEL mutations
|
Wine, Jeffrey J.
|
|
|
23 |
6 |
p. 1180-1184
|
artikel
|
| 3 |
Cardiac Structure and Function in People with Cystic Fibrosis
|
Duus, Lisa Steen
|
|
|
23 |
6 |
p. 1138-1145
|
artikel
|
| 4 |
Changes in exercise capacity in people with Cystic Fibrosis after one year of Elexacaftor/Tezacaftor/Ivacaftor treatment – A Danish prospective cohort
|
Philipsen, Lue Katrine Drasbæk
|
|
|
23 |
6 |
p. 1080-1086
|
artikel
|
| 5 |
Changes in urinary glutathione sulfonamide (GSA) levels between admission and discharge of patients with cystic fibrosis
|
Blake, Tamara L
|
|
|
23 |
6 |
p. 1163-1166
|
artikel
|
| 6 |
Clinical outcomes after liver transplant in people with cystic fibrosis: A systematic review and meta-analysis
|
Albaiz, Faisal A.
|
|
|
23 |
6 |
p. 1112-1121
|
artikel
|
| 7 |
Contents
|
|
|
|
23 |
6 |
p. i-iii
|
artikel
|
| 8 |
Creation of a CF-specific antibiotic spectrum index (ASI) as an antimicrobial stewardship initiative
|
Cogen, Jonathan D.
|
|
|
23 |
6 |
p. 1159-1162
|
artikel
|
| 9 |
Cystic fibrosis foundation position paper: Redefining the CF care model
|
Goetz, D.M.
|
|
|
23 |
6 |
p. 1055-1065
|
artikel
|
| 10 |
Cystic fibrosis foundation position paper: Redefining the cystic fibrosis care team
|
Brown, Rebekah F.
|
|
|
23 |
6 |
p. 1045-1054
|
artikel
|
| 11 |
Development and preliminary validation of the personalized cystic fibrosis medication questionnaire (PCF-MQ)
|
Phan, Hanna
|
|
|
23 |
6 |
p. 1100-1105
|
artikel
|
| 12 |
Echocardiographic assessment of cardiovascular involvements in children with cystic fibrosis
|
Ghaffaripour, Hosseinali
|
|
|
23 |
6 |
p. 1134-1137
|
artikel
|
| 13 |
Elexacaftor/Tezacaftor/Ivacaftor use in Pediatric Cystic Fibrosis Patients with Advanced Liver Disease
|
Protich, Hannah E
|
|
|
23 |
6 |
p. 1122-1128
|
artikel
|
| 14 |
Establishment of a conditionally reprogrammed primary eccrine sweat gland culture for evaluation of tissue-specific CFTR function
|
Eastman, Alice C.
|
|
|
23 |
6 |
p. 1173-1179
|
artikel
|
| 15 |
Heterogeneity in response to Elexacaftor/Tezacaftor/Ivacaftor in people with cystic fibrosis
|
Alicandro, Gianfranco
|
|
|
23 |
6 |
p. 1072-1079
|
artikel
|
| 16 |
Identifying people living with cystic fibrosis in the Danish National Patient Registry: A validation study
|
Råket, Hans Kristian
|
|
|
23 |
6 |
p. 1095-1099
|
artikel
|
| 17 |
Letter to the Editor
|
Khajeh, Atefeh
|
|
|
23 |
6 |
p. 1199
|
artikel
|
| 18 |
Metabolomics analysis of bronchoalveolar lavage fluid predicts unique features of the lower airway in pediatric cystic fibrosis
|
O'Connor, John B.
|
|
|
23 |
6 |
p. 1087-1094
|
artikel
|
| 19 |
News article
|
|
|
|
23 |
6 |
p. 1033-1034
|
artikel
|
| 20 |
Olfactory loss in people with cystic fibrosis: Community perceptions and impact
|
Miller, Jessa E.
|
|
|
23 |
6 |
p. 1195-1198
|
artikel
|
| 21 |
Outcomes of a cross-sectional ultrasound- based study of cystic fibrosis related liver disease: A real world experience
|
Kurkal, Kavya
|
|
|
23 |
6 |
p. 1129-1133
|
artikel
|
| 22 |
Repurposing DNase I and alginate lyase to degrade the biofilm matrix of dual-species biofilms of Staphylococcus aureus and Pseudomonas aeruginosa grown in artificial sputum medium: In-vitro assessment of their activity in combination with broad-spectrum antibiotics
|
Wang, Zhifen
|
|
|
23 |
6 |
p. 1146-1152
|
artikel
|
| 23 |
Role of viable but non culturable cells in patients with cystic fibrosis in the era of highly effective modulator therapy
|
Cirilli, Natalia
|
|
|
23 |
6 |
p. 1153-1158
|
artikel
|
| 24 |
Room to breathe: The promise of a more flexible cystic fibrosis care model
|
Bruening Wajda, Katherine
|
|
|
23 |
6 |
p. 1038-1039
|
artikel
|
| 25 |
Staying agile: Adapting care to meet changing healthcare needs of people with cystic fibrosis
|
Brown, Rebekah F.
|
|
|
23 |
6 |
p. 1040-1042
|
artikel
|
| 26 |
Symptom phenotyping in people with cystic fibrosis during acute pulmonary exacerbations using machine-learning K-means clustering analysis
|
Gill, Eliana R.
|
|
|
23 |
6 |
p. 1106-1111
|
artikel
|
| 27 |
Tezacaftor is a direct inhibitor of sphingolipid delta-4 desaturase enzyme (DEGS)
|
Ciobanu, Dinu Zinovie
|
|
|
23 |
6 |
p. 1167-1172
|
artikel
|
| 28 |
The day after. Rethinking the Cystic Fibrosis model of care and structure of the CF team in the era of triple combination therapy
|
Reix, Philippe
|
|
|
23 |
6 |
p. 1043-1044
|
artikel
|
| 29 |
TLN468 changes the pattern of tRNA used to read through premature termination codons in CFTR
|
Karri, Sabrina
|
|
|
23 |
6 |
p. 1185-1194
|
artikel
|
| 30 |
Wobbly moments: Trust considerations for evolving cystic fibrosis care models
|
Van Gorp, Stacy
|
|
|
23 |
6 |
p. 1035-1037
|
artikel
|
Tijdschrift beschrijving